Norepinephrine-stimulated MAP kinase activity enhances cytokine-induced NO production by rat cardiac myocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 1 45-1, 1999, Pages

  Kan, Hong ^a   Xie, Zirong ^a   Finkel, Mitchell S ^a,b,c  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Adrenergic receptors; Cell signaling; Interleukin 1 ; Protein kinases

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE; NORADRENALIN; PRAZOSIN; PROPRANOLOL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME MECHANISM; HEART MUSCLE CELL; INFLAMMATION; NEWBORN; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

EID: 33746543606     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.1.h47     Document Type: Article

References (23)

1. Abbas, A. K., A. H. Lichtman, and J. S. Pober. Cellular and Molecular Immunology. Philadelphia, PA: Saunders, 1991, p. 226-242.
2. Balligand, J. L., D. Ungureanu-Longrois, W. W. Simmons, D. Pimental, T. A. Malinski, M. Kapturczak, Z. Taha, C. J. Lowenstein, A. J. Davidoff, R. A. Kelly, T. W. Smith, and T. Michel. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J. Biol. Chem. 269: 27580-27588, 1994.
3. Bredt, D. S., P. M. Hwang, C. E. Glatt, C. Lowenstein, R. R. Reed, and S. H. Snyder. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351: 714-718, 1991.
4. Duff, J. L., B. P. Monia, and B. C. Berk. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. J. Biol. Chem. 270: 7161-7166, 1995.
5. Finkel, M. S., C. V. Oddis, T. D. Jacob, S. L. Watkins, B. G. Hattler, and R. L. Simmons. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389, 1992.
6. Gilman, A. G., T. W. Rail, A. S. Nies, and P. Taylor. Goodman and Gilman's The Pharmacologic Basis of Therapeutics (8th ed.). New York: Pergamon, 1990, p. 187-243.
7. Ignarro, L. J. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41: 485-490, 1991.
8. Janssens, S. P., A. Shimouchi, T. Quertermous, D. B. Bloch, and K. D. Bloch. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267: 14519-14522, 1992.
9. Kanai, A. J., S. Mesaros, M. S. Finkel, C. V. Oddis, L. A. Birder, and T. Malinski. β-Adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes. Am. J. Physiol. 273 (Cell Physiol. 42): C1371-C1377, 1997.
10. Milligan, G. Mechanisms of mulitifunctional signalling by G protein-linked receptors. Trends Pharmacol. Sci. 14: 239-244, 1993.
11. Moncada, S., and A. Higgs. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
12. Oddis, C. V., and M. S. Finkel. Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem. Biophys. Res. Commun. 213: 1002-1009, 1995.
13. Oddis, C., V., R. L. Simmons, B. G. Hattler, and M. S. Finkel. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H2044-H2050, 1995.
14. Oddis, C. V., R. L. Simmons, B. G. Hattler, and M. S. Finkel. Protein kinase A activation is required for IL-1-induced nitric oxide production by cardiac myocytes. Am. J. Physiol. 271 (Cell Physiol. 40): C429-C434, 1996.
15. Packer, M., M. R. Bristow, J. N. Cohn, W. S. Colucci, M. B. Fowler, E. M. Gilbert, and N. H. Shusterman. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N. Engl. J. Med. 334: 1349-1355, 1996.
16. Pelech, S. L., and J. S. Sanghera. MAP kinase: charting the regulatory pathways. Science 257: 1355-1356, 1993.
17. 1-adrenergic receptor interaction. Circ. Res. 56: 884-889, 1985.
18. Singh, K., J. Balligand, T. A. Fischer, T. W. Smith, and R. A. Kelly. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular cell. J. Biol. Chem. 271: 1111-1117, 1996.
19. Talosi, L., and E. G. Kranias. Effect of α-adrenergic stimulation on activation of protein kinase C and phosphorylation of proteins in intact rabbit heart. Circ. Res. 70: 670-678, 1992.
20. Thomas, J. A., and B. H. Marks. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 41: 233-241, 1978.
21. Walters, S. B., K. H. Holt, S. E. Ross, L. J. Syu, K. L. Guan, A. R. Saltiel, G. A. Koretzky, and J. E. Pessin. Desensitization of ras activation by a feedback disassociation of the SOS-Grb2 complex. J. Biol. Chem. 270: 20883-20886, 1995.
22. 1 and β-adrenoceptors. Circulation 59: 1260-1268, 1997.
23. Yang, X., M. Szabolcs, E. Athan, O. P. Minanov, R. R. Sciacca, M. Bianchi, P. Ulrich, K. J. Tracey, R. E. Michler, and P. J. Cannon. CNI-1493 reduces apoptosis and necrosis and prolongs survival during rat cardiac allograft rejection (Abstract). Circulation 94: 1-55, 1996.